ICC in patients with massive bleeding was reduced by 45.64 %, ICD was less than normal at 59.32 %, MA was reduced by 88.15 %, IRCL was 86,16 % above the norm.
While major bleeding was reduced by 50%% with dabigatran compared with warfarin, it did not achieve statistical significance (p = 0.06).
In the subgroup of studies (14 studies, 10 260 patients) using intravenous enoxaparin, major bleeding was reduced by 34% compared with unfractionated heparin (0.66, 0.52 to 0.83; P<0.001, P for heterogeneity 0.9; absolute risk reduction 1.52%; NNT=66).
The gate settings are found by minimising the artifacts introduced to the desirable component of the signal, whilst ensuring that the level of bleed is reduced by a certain amount.
Bleeding of free water is reduced by using fly ash because of the increase of solids and therefore less segregation of the solids [9].
The sensitivity of this method is reduced by UGI bleeding when polyclonal ELISA or immunochromatographic stool antigens are used [ 38, 60, 61].
In particular, a CES1 polymorphism significantly reduces the concentration of dabigatran in blood by 15%, and risk of bleeding was reduced of 33% [140].
In a retrospective study by Agerstrand et al., incidence of bleeding was reduced and circuit or oxygenator thrombosis was rare, using a low target aPTT [25].
For instance, the risk of GI bleeding is increased by administration of NSAIDs, advanced age and liver disease, but is reduced by administration of PPI and H2 blockers.
Infectivity is reduced by ARV use.
